Brompton Global Healthcare Inc & Gr ETF (HIG.TO)

9.05 +0.00  +0.00% TSX May 22, 20:00 Delayed 15m CAD
View Full Chart
Price Chart

Key Stats

Net Asset Value 9.052
Discount or Premium to NAV -0.02%
Turnover Ratio 71.94%
1 Year Fund Level Flows 3.704M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 1.11% 0.85% -- --
3M -6.83% -6.90% -- --
6M -0.33% -0.42% -- --
YTD -5.68% -4.55% -- --
1Y 7.66% 7.97% -- --
3Y -- 6.53% -- --
5Y -- -- -- --
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of May 22, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 0.47% 0.47% 0.00%
Stock 99.53% 99.53% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of April 30, 2020

Region Exposure

Americas 73.54%
North America 73.54%
Latin America 0.00%
Greater Europe 26.46%
United Kingdom 6.70%
Europe Developed 19.76%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets --
As of April 30, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of April 30, 2020

Stock Market Capitalization

Giant 62.99%
Large 33.24%
Medium 3.76%
Small 0.00%
Micro 0.00%
As of April 30, 2020

Stock Style Exposure

Large Cap Value 14.08%
Large Cap Blend 61.98%
Large Cap Growth 20.17%
Mid Cap Value 0.00%
Mid Cap Blend 0.00%
Mid Cap Growth 3.76%
Small Cap Value 0.00%
Small Cap Blend 0.00%
Small Cap Growth 0.00%
As of April 30, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
AZN AstraZeneca PLC ADR 4.55% 55.22 -0.11%
ROG Roche Holding AG Dividend Right Cert. 4.38% -- --
ABT Abbott Laboratories 4.33% 91.47 +1.19%
PFE Pfizer Inc 4.17% 37.50 +0.64%
HUM Humana Inc 4.13% 394.43 -0.21%
BDX Becton, Dickinson and Co 4.09% 239.25 +0.13%
TMO Thermo Fisher Scientific Inc 4.04% 340.26 +1.34%
EW Edwards Lifesciences Corp 4.02% 218.81 +0.14%
NVO Novo Nordisk A/S ADR 3.93% 64.83 +0.02%
BAX Baxter International Inc 3.91% 86.93 +0.43%
As of April 30, 2020
Advertisement

Basic Info

Investment Strategy
The investment objectives of HIG are to provide holders of Units of HIG (the “HIG Unitholders”) with: (i) stable monthly cash distributions; (ii) the opportunity for capital appreciation; and (iii) lower overall volatility of portfolio returns than would otherwise be experienced by owning securities of Healthcare Companies (as defined herein) directly. HIG seeks to hedge substantially all of its exposure to foreign currencies back to the Canadian dollar.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap/Blend
Fixed Income Style --
Broad Asset Class --
Broad Category Equity
Category Name Sector Equity
Prospectus Objective --
Fund Owner Firm Name Brompton Funds Limited
Benchmark Index
MSCI World Health Care GR 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Not Disclosed 4.52 yrs

Net Fund Flows

1M 864595.0
3M 2.767M
6M 3.726M
YTD 3.250M
1Y 3.704M
3Y --
5Y --
10Y --
As of April 30, 2020

Risk Info

Beta (5Y) --
Max Drawdown (All) 31.82%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.1652
30-Day Rolling Volatility 23.45%
Daily Value at Risk (VaR) 1% (All) 6.42%
Monthly Value at Risk (VaR) 1% (All) 24.69%

Fundamentals

Dividend Yield TTM (5-22-20) 6.63%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 26.80
Weighted Average Price to Sales Ratio 3.510
Weighted Average Price to Book Ratio 4.758
Weighted Median ROE 27.54%
Weighted Median ROA 9.90%
Forecasted Dividend Yield 2.01%
Forecasted PE Ratio 19.26
Forecasted Price to Sales Ratio 3.345
Forecasted Price to Book Ratio 4.784
Number of Holdings 30
As of April 30, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 9.39%
Forecasted Book Value Growth 2.20%
Forecasted Cash Flow Growth 10.01%
Forecasted Earnings Growth 12.49%
Forecasted Revenue Growth 7.22%
As of April 30, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 9/24/2015
Termination Date
Last Annual Report Date 12/31/2019
Last Prospectus Date 3/26/2020
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP Yes
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.